EGFR and cancer: Comprehensively, a gefitinib/ginsenoside Rg3 interval sequential dosing regimen was carried out to fully achieve the anti-cancer effect with gefitinib alone continuous dosing, and also further confirmed the correlation between the effect of ginsenoside Rg3 and EGFR content when combined with gefitinib.